Literature DB >> 26830054

Establishing the validity of different susceptibility testing methods to evaluate the in vitro activity of amoxicillin-clavulanate against Escherichia coli.

Díez-Aguilar María1, Morosini María-Isabel1, Conejo María-Carmen2, Pascual Álvaro3, Calvo Jorge4, Martínez-Martínez Luis5, Marco Francesc6, Vila Jordi6, Ortega Adriana7, Oteo Jesús7, Cantón Rafael8.   

Abstract

Amoxicillin-clavulanate MICs of 160 Escherichia coli isolates with characterized resistance mechanisms were obtained by 2 MIC gradient strip brands, 3 automated systems, and reference ISO microdilution method using EUCAST (fixed 2μg/mL clavulanate) and CLSI (2:1 ratio) criteria. Discrepancies, mainly obtained with gradient strips, lead to an essential agreement range of 76.2-92.5.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amoxicillin-clavulanate; Automated systems; Escherichia coli; MIC-gradient strips

Mesh：

Substances：

Year:  2015        PMID： 26830054     DOI： 10.1016/j.diagmicrobio.2015.12.012

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  1 in total

1.  Reconciling the Potentially Irreconcilable? Genotypic and Phenotypic Amoxicillin-Clavulanate Resistance in Escherichia coli.

Authors:  Timothy J Davies; Nicole Stoesser; Anna E Sheppard; Manal Abuoun; Philip Fowler; Jeremy Swann; T Phuong Quan; David Griffiths; Alison Vaughan; Marcus Morgan; Hang T T Phan; Katie J Jeffery; Monique Andersson; Matt J Ellington; Oskar Ekelund; Neil Woodford; Amy J Mathers; Robert A Bonomo; Derrick W Crook; Tim E A Peto; Muna F Anjum; A Sarah Walker
Journal:  Antimicrob Agents Chemother       Date:  2020-05-21       Impact factor: 5.191
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.